{
  "name": "Vertex Pharmaceuticals",
  "slug": "vertex-pharmaceuticals",
  "ticker": "VRTX",
  "fetched_at": "2026-02-08T12:28:10.184122+00:00",
  "news": [
    {
      "title": "Is Vertex Pharmaceuticals (VRTX) Pricing Reflect Long Term Cash Flow Potential After Recent Pullback - Yahoo Finance",
      "link": "https://news.google.com/rss/articles/CBMikwFBVV95cUxNR2hkWUhDam53M1R4MEJHX21iZ284d3ZkQWs3eXY1ZXJmYzBpYVVvSjhEeTdpVDVjdHh3aUlFWmtLck91WGNEVHdGTUUybDlCdEdWMkxGTG80Y2NTR1otUWt5Zk5VMmpXN21UenNhMlJFZ2tJRzllemF0bDJtS3dYQl9zVmZVRngya2JKUzVYdXg2QlE?oc=5",
      "summary": "<a href=\"https://news.google.com/rss/articles/CBMikwFBVV95cUxNR2hkWUhDam53M1R4MEJHX21iZ284d3ZkQWs3eXY1ZXJmYzBpYVVvSjhEeTdpVDVjdHh3aUlFWmtLck91WGNEVHdGTUUybDlCdEdWMkxGTG80Y2NTR1otUWt5Zk5VMmpXN21UenNhMlJFZ2tJRzllemF0bDJtS3dYQl9zVmZVRngya2JKUzVYdXg2QlE?oc=5\" target=\"_blank\">Is Vertex Pharmaceuticals (VRTX) Pricing Reflect Long Term Cash Flow Potential After Recent Pullback</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">Yahoo Finance</font>",
      "published": "2026-02-05T08:10:54+00:00",
      "source": "Yahoo Finance"
    },
    {
      "title": "Prediction: 2026 Will Be the Year of Vertex Pharmaceuticals - The Motley Fool",
      "link": "https://news.google.com/rss/articles/CBMimAFBVV95cUxPZG5FX0otdUtWQXFNcVJHS2FaUnRjNFNmbHB6NURFN1pBdUxlZllFMmFaeE93U3FUSF9kT0RxS0ZWMzFrMnFmUnVvNS1XX2VRVjEwTHpYUUNidXVYZjktZ2RrRlhRWUpQTUgyWklsV1BIemJNNkh6dlBsdC0yYUluRDBBeFdIX1RtNjBOS1Vhb3RwU3JRWEJ4MA?oc=5",
      "summary": "<a href=\"https://news.google.com/rss/articles/CBMimAFBVV95cUxPZG5FX0otdUtWQXFNcVJHS2FaUnRjNFNmbHB6NURFN1pBdUxlZllFMmFaeE93U3FUSF9kT0RxS0ZWMzFrMnFmUnVvNS1XX2VRVjEwTHpYUUNidXVYZjktZ2RrRlhRWUpQTUgyWklsV1BIemJNNkh6dlBsdC0yYUluRDBBeFdIX1RtNjBOS1Vhb3RwU3JRWEJ4MA?oc=5\" target=\"_blank\">Prediction: 2026 Will Be the Year of Vertex Pharmaceuticals</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">The Motley Fool</font>",
      "published": "2026-01-29T08:00:00+00:00",
      "source": "The Motley Fool"
    },
    {
      "title": "Assessing Vertex Pharmaceuticals (VRTX) Valuation After Autoimmune Pipeline Expansion With WuXi Biologics - simplywall.st",
      "link": "https://news.google.com/rss/articles/CBMi7AFBVV95cUxOMWw0RnlVX3Q2MW5lZlNWSmVKRnpJWnVaS3lhbzRpNWZxeTlFSWtxYWM4X3dpRTc5NVJqbThneV81ZzcxNnV3SVBjSUpHYV9kNEFRajFlTE9kOW5oT2k2VTRPd3NwajM2MjNMSXdYcENUakljVE5RaHdQemlmOTVWbVBDQlVEZWhDU3lCaWZMcDdkaTd2SFROaVg4ZjY4M1BUd1M0NTBRczdHM1lGaVN4dXFSZ3E2T1lVU1JOazVoRC14Z3kxbG5Ec1YwZWs2YUJOUWZscmtxRHFxejVsblJqNXRKNml3YU5GVGZiWQ?oc=5",
      "summary": "<a href=\"https://news.google.com/rss/articles/CBMi7AFBVV95cUxOMWw0RnlVX3Q2MW5lZlNWSmVKRnpJWnVaS3lhbzRpNWZxeTlFSWtxYWM4X3dpRTc5NVJqbThneV81ZzcxNnV3SVBjSUpHYV9kNEFRajFlTE9kOW5oT2k2VTRPd3NwajM2MjNMSXdYcENUakljVE5RaHdQemlmOTVWbVBDQlVEZWhDU3lCaWZMcDdkaTd2SFROaVg4ZjY4M1BUd1M0NTBRczdHM1lGaVN4dXFSZ3E2T1lVU1JOazVoRC14Z3kxbG5Ec1YwZWs2YUJOUWZscmtxRHFxejVsblJqNXRKNml3YU5GVGZiWQ?oc=5\" target=\"_blank\">Assessing Vertex Pharmaceuticals (VRTX) Valuation After Autoimmune Pipeline Expansion With WuXi Biologics</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">simplywall.st</font>",
      "published": "2026-02-06T16:10:01+00:00",
      "source": "simplywall.st"
    },
    {
      "title": "Working at Vertex - vrtx.com",
      "link": "https://news.google.com/rss/articles/CBMiRkFVX3lxTFA5V0I2MlFxR2EzeXBQQUdHWUt1bmVXVXZ1eFRHSUtlZTBnaDZOQjBoa3AzcU81aFZJa1dOSHFFcHRpamxqNVE?oc=5",
      "summary": "<a href=\"https://news.google.com/rss/articles/CBMiRkFVX3lxTFA5V0I2MlFxR2EzeXBQQUdHWUt1bmVXVXZ1eFRHSUtlZTBnaDZOQjBoa3AzcU81aFZJa1dOSHFFcHRpamxqNVE?oc=5\" target=\"_blank\">Working at Vertex</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">vrtx.com</font>",
      "published": "2025-06-02T15:34:51+00:00",
      "source": "vrtx.com"
    },
    {
      "title": "The Bond Market Is Flashing a Clear Warning About the Fed: 3 Stocks to Buy - The Globe and Mail",
      "link": "https://news.google.com/rss/articles/CBMi5AFBVV95cUxQTEZrelJqNHY0cnpYcmdvbW5IWEh0WlgzY1VwNnZ2OXZaVkJrT1VOeFY0bW54blFiWkNhYWptbEhlcTRtNTVaVnpKTXhma0RQeEgzTEJJTTctWlAtMzdvbWRWc25GRUgyZHIxQVRFY094cGhSRm94VE5TYnlkdG9ob1ZaRlZhSjdzMHFZcGI5bnRjTkdNVnYyY0xHYzZFMVZhNUlFaVlRTkVJRGJkZnhYR1pIMU5YZlZsMlZIXzM0aklpT29vTTVhM3lRazlHNTI5N0Y1cEtQbndVVktHZ3NrZ3IzbWo?oc=5",
      "summary": "<a href=\"https://news.google.com/rss/articles/CBMi5AFBVV95cUxQTEZrelJqNHY0cnpYcmdvbW5IWEh0WlgzY1VwNnZ2OXZaVkJrT1VOeFY0bW54blFiWkNhYWptbEhlcTRtNTVaVnpKTXhma0RQeEgzTEJJTTctWlAtMzdvbWRWc25GRUgyZHIxQVRFY094cGhSRm94VE5TYnlkdG9ob1ZaRlZhSjdzMHFZcGI5bnRjTkdNVnYyY0xHYzZFMVZhNUlFaVlRTkVJRGJkZnhYR1pIMU5YZlZsMlZIXzM0aklpT29vTTVhM3lRazlHNTI5N0Y1cEtQbndVVktHZ3NrZ3IzbWo?oc=5\" target=\"_blank\">The Bond Market Is Flashing a Clear Warning About the Fed: 3 Stocks to Buy</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">The Globe and Mail</font>",
      "published": "2026-02-08T08:28:25+00:00",
      "source": "The Globe and Mail"
    },
    {
      "title": "Vertex Pharmaceuticals Stock Slid 5% This Week. Here’s What Changed - TIKR.com",
      "link": "https://news.google.com/rss/articles/CBMilAFBVV95cUxNOUhDbC1aTHJYVDQzaGhCUWp2eFg0bTB2TWFqaDVhYklmVVZTQm00cUxKVVhUaVBPZ1JJOFpiVDIzM3VPMnJXVjFQcnFaMDBMZmNPNzlwOFRNQUJCdXVyZ1J0QzVTcmM4eTFlVkJUb3NsRmExakd4YWdEOVdqQ1dlbHVmSzJXampmQjFXNTNsWjE4a2l4?oc=5",
      "summary": "<a href=\"https://news.google.com/rss/articles/CBMilAFBVV95cUxNOUhDbC1aTHJYVDQzaGhCUWp2eFg0bTB2TWFqaDVhYklmVVZTQm00cUxKVVhUaVBPZ1JJOFpiVDIzM3VPMnJXVjFQcnFaMDBMZmNPNzlwOFRNQUJCdXVyZ1J0QzVTcmM4eTFlVkJUb3NsRmExakd4YWdEOVdqQ1dlbHVmSzJXampmQjFXNTNsWjE4a2l4?oc=5\" target=\"_blank\">Vertex Pharmaceuticals Stock Slid 5% This Week. Here’s What Changed</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">TIKR.com</font>",
      "published": "2026-01-18T08:00:00+00:00",
      "source": "TIKR.com"
    },
    {
      "title": "Vertex’s CRISPR treatment for sickle cell disease hits unexpected roadblock - statnews.com",
      "link": "https://news.google.com/rss/articles/CBMiqAFBVV95cUxQdTg3QndmcEpXVGpOU0tqUU9NYzNGUEc0OV9fb1hISEhkRE1xQ1JFWjU3ZlRQcXF1dmxnOEg0bUdCcU5RWFZQU0ZvSHNhR05fRGN3enlLeU5ScjFwUEF2bmxJTzZ0TURhYkdJY0pJbTZHWHFtc3hJZ2JLSU5ZZkFXcm1yMjBKZklPSDN2NDZrT0NITUlST0FZVHI1N19qM1FaVzg5eFpFVUE?oc=5",
      "summary": "<a href=\"https://news.google.com/rss/articles/CBMiqAFBVV95cUxQdTg3QndmcEpXVGpOU0tqUU9NYzNGUEc0OV9fb1hISEhkRE1xQ1JFWjU3ZlRQcXF1dmxnOEg0bUdCcU5RWFZQU0ZvSHNhR05fRGN3enlLeU5ScjFwUEF2bmxJTzZ0TURhYkdJY0pJbTZHWHFtc3hJZ2JLSU5ZZkFXcm1yMjBKZklPSDN2NDZrT0NITUlST0FZVHI1N19qM1FaVzg5eFpFVUE?oc=5\" target=\"_blank\">Vertex’s CRISPR treatment for sickle cell disease hits unexpected roadblock</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">statnews.com</font>",
      "published": "2026-02-05T09:37:11+00:00",
      "source": "statnews.com"
    },
    {
      "title": "Vertex Pharmaceuticals Inc (NASDAQ:VRTX) Presents a Compelling Growth and Breakout Opportunity - Chartmill",
      "link": "https://news.google.com/rss/articles/CBMi2wFBVV95cUxOajA1Umd2MW55SXAwVzN2eV9ZSkt5Ym80TEFUZXdvYWV2OFpMM1A3VzVPR3pUUGJLUGVWcXA2MEdwbzBxUFlxMlhwOWtSbTB5QVpjcjBBdHBrMW42RGJZeVhpNjVUX1lYU0FtcVdBQ2Y3LVhlX0dqYlZxUmI1YUxHT1FuOWFWQVdoQW1tTEJadW5QYWZSWFltQXdENDZ4RERaY1NwbjNURHpCYTdEYUthVEJGQlNXVnBJY0F4MGdxMWFJQTNPS3hUT3RuS0lyeXh3ajdUdHJtSnBLVGs?oc=5",
      "summary": "<a href=\"https://news.google.com/rss/articles/CBMi2wFBVV95cUxOajA1Umd2MW55SXAwVzN2eV9ZSkt5Ym80TEFUZXdvYWV2OFpMM1A3VzVPR3pUUGJLUGVWcXA2MEdwbzBxUFlxMlhwOWtSbTB5QVpjcjBBdHBrMW42RGJZeVhpNjVUX1lYU0FtcVdBQ2Y3LVhlX0dqYlZxUmI1YUxHT1FuOWFWQVdoQW1tTEJadW5QYWZSWFltQXdENDZ4RERaY1NwbjNURHpCYTdEYUthVEJGQlNXVnBJY0F4MGdxMWFJQTNPS3hUT3RuS0lyeXh3ajdUdHJtSnBLVGs?oc=5\" target=\"_blank\">Vertex Pharmaceuticals Inc (NASDAQ:VRTX) Presents a Compelling Growth and Breakout Opportunity</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">Chartmill</font>",
      "published": "2026-02-02T10:01:44+00:00",
      "source": "Chartmill"
    }
  ],
  "product_launches": [
    {
      "title": "Strong Product Launches and Upbeat Guidance Could Be a Game Changer for Vertex Pharmaceuticals (VRTX) - Yahoo Finance",
      "link": "https://news.google.com/rss/articles/CBMijgFBVV95cUxNOFZFNHZzSk1rSnJWVTEwWExLd1FvWVBPUkVkTV9TRG1oUWdTbWgzbWNkdlA3MkVLNmVra3NUUWhBQWFXZ3c5LVNxZFRkWDhkMUZ1QVlUXzg3ZEZwOHY3TTRjMEYxUjlwZFhYVW84QUVXX0lQaTZVbDN4Qk5WM1NQX0EwSVJXZ2piZXl4d3ZB?oc=5",
      "summary": "<a href=\"https://news.google.com/rss/articles/CBMijgFBVV95cUxNOFZFNHZzSk1rSnJWVTEwWExLd1FvWVBPUkVkTV9TRG1oUWdTbWgzbWNkdlA3MkVLNmVra3NUUWhBQWFXZ3c5LVNxZFRkWDhkMUZ1QVlUXzg3ZEZwOHY3TTRjMEYxUjlwZFhYVW84QUVXX0lQaTZVbDN4Qk5WM1NQX0EwSVJXZ2piZXl4d3ZB?oc=5\" target=\"_blank\">Strong Product Launches and Upbeat Guidance Could Be a Game Changer for Vertex Pharmaceuticals (VRTX)</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">Yahoo Finance</font>",
      "published": "2025-08-22T07:00:00+00:00",
      "source": "Yahoo Finance"
    },
    {
      "title": "Vertex’s new pain, blood disorder drugs miss Wall Street expectations - BioPharma Dive",
      "link": "https://news.google.com/rss/articles/CBMimgFBVV95cUxPSzdmS1NOZmlSUk5NZGNNbXdJdi1FajV2ZzVYQU5zaXVxVEV3RnFqNG1MUk9EMEtBT0h1Z1JpOEJsQU1Uek4wRUQtZ1dwc3NxVXlrU2dJbDdNNnplVUxrWkJzMHFreHZqUmFOYktWY2ZLLWtBV2tJZGNvSXFkdGVETXNiNkd1UHR2SFQxTmFIdktQSzFhbzc5a1BR?oc=5",
      "summary": "<a href=\"https://news.google.com/rss/articles/CBMimgFBVV95cUxPSzdmS1NOZmlSUk5NZGNNbXdJdi1FajV2ZzVYQU5zaXVxVEV3RnFqNG1MUk9EMEtBT0h1Z1JpOEJsQU1Uek4wRUQtZ1dwc3NxVXlrU2dJbDdNNnplVUxrWkJzMHFreHZqUmFOYktWY2ZLLWtBV2tJZGNvSXFkdGVETXNiNkd1UHR2SFQxTmFIdktQSzFhbzc5a1BR?oc=5\" target=\"_blank\">Vertex’s new pain, blood disorder drugs miss Wall Street expectations</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">BioPharma Dive</font>",
      "published": "2025-11-04T08:00:00+00:00",
      "source": "BioPharma Dive"
    },
    {
      "title": "Vertex’s New Products Dim as Analysts Eye Kidney Portfolio - BioSpace",
      "link": "https://news.google.com/rss/articles/CBMilgFBVV95cUxObHk5T3lvemFXaFY4LXUwYkNCRHBBNk1KQ1gwVFZ5Wmw2RW4xTEpWcXFoZ3YtaXJUUWd3c0Z3U0xnSkU3Q0VHUkhqVjh1cTJKME9FY0kzSDRGN2pIaWh5MDlyUVU3OHY0WEFCRHpnaXdEUkFZTWRxeWdvQWU1MVBBZ0FNRXZKLU45RUFQb2F2UmRjTmw2UGc?oc=5",
      "summary": "<a href=\"https://news.google.com/rss/articles/CBMilgFBVV95cUxObHk5T3lvemFXaFY4LXUwYkNCRHBBNk1KQ1gwVFZ5Wmw2RW4xTEpWcXFoZ3YtaXJUUWd3c0Z3U0xnSkU3Q0VHUkhqVjh1cTJKME9FY0kzSDRGN2pIaWh5MDlyUVU3OHY0WEFCRHpnaXdEUkFZTWRxeWdvQWU1MVBBZ0FNRXZKLU45RUFQb2F2UmRjTmw2UGc?oc=5\" target=\"_blank\">Vertex’s New Products Dim as Analysts Eye Kidney Portfolio</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">BioSpace</font>",
      "published": "2025-11-04T08:00:00+00:00",
      "source": "BioSpace"
    },
    {
      "title": "Vertex Pharmaceuticals Stock is Down 4% Despite Strong Q3 Results - TIKR.com",
      "link": "https://news.google.com/rss/articles/CBMipAFBVV95cUxNWmctaU5ocDNJQkhYeWU1TE9id3plcjdPcE1jR0NYZ2hFMVp6VXJtbzRSMEVRdGo3Z1VYaElRVzlJQ2JOV2F6OFJORlJudEJQMVhzMDExMUZ4Nnc2dlNIaWhjbVJPa2tCVlZzOGVRcmUyVDhfWi1kM2liNTlINmhlN2lRUHZKSEhXWWdCakVkQ0Vhb2l6SElFdzFfdHFJcF9qUy1KaQ?oc=5",
      "summary": "<a href=\"https://news.google.com/rss/articles/CBMipAFBVV95cUxNWmctaU5ocDNJQkhYeWU1TE9id3plcjdPcE1jR0NYZ2hFMVp6VXJtbzRSMEVRdGo3Z1VYaElRVzlJQ2JOV2F6OFJORlJudEJQMVhzMDExMUZ4Nnc2dlNIaWhjbVJPa2tCVlZzOGVRcmUyVDhfWi1kM2liNTlINmhlN2lRUHZKSEhXWWdCakVkQ0Vhb2l6SElFdzFfdHFJcF9qUy1KaQ?oc=5\" target=\"_blank\">Vertex Pharmaceuticals Stock is Down 4% Despite Strong Q3 Results</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">TIKR.com</font>",
      "published": "2025-11-04T08:00:00+00:00",
      "source": "TIKR.com"
    },
    {
      "title": "Vertex tops estimates on cystic fibrosis treatment strength, new products - Reuters",
      "link": "https://news.google.com/rss/articles/CBMi2AFBVV95cUxQV1RfcWFhZlB4RnlGTUNfYlJTOEFKaHREZHlEeV9GVHpnaW1zRDliVlMtX3dWdjZkS2RNRWhZaXc0NmdVcW10bVhmQV9NNlh3b3IwckhEME9rTFlIci1hRDF4RlFzRWprOWFTdjlVV1d4dVpIaVFGWXBiWF9tbnJmcFEydUxiNDF1TVJfLTI4QmtvcnIwWVhYd3hNTno2aFhpZF9WNFZjX3lJLVVsNjZfcWZOVTVzU2lXYzV1cmw0bDRpTUFiWjJLUElvRk15d1RKLWJnQy10MmU?oc=5",
      "summary": "<a href=\"https://news.google.com/rss/articles/CBMi2AFBVV95cUxQV1RfcWFhZlB4RnlGTUNfYlJTOEFKaHREZHlEeV9GVHpnaW1zRDliVlMtX3dWdjZkS2RNRWhZaXc0NmdVcW10bVhmQV9NNlh3b3IwckhEME9rTFlIci1hRDF4RlFzRWprOWFTdjlVV1d4dVpIaVFGWXBiWF9tbnJmcFEydUxiNDF1TVJfLTI4QmtvcnIwWVhYd3hNTno2aFhpZF9WNFZjX3lJLVVsNjZfcWZOVTVzU2lXYzV1cmw0bDRpTUFiWjJLUElvRk15d1RKLWJnQy10MmU?oc=5\" target=\"_blank\">Vertex tops estimates on cystic fibrosis treatment strength, new products</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">Reuters</font>",
      "published": "2025-08-04T07:00:00+00:00",
      "source": "Reuters"
    }
  ],
  "stock": {
    "ticker": "VRTX",
    "currency": "USD",
    "latest": {
      "date": "2026-02-06",
      "close": 477.9200134277344
    },
    "history": [
      {
        "date": "2026-01-29",
        "close": 475.67999267578125
      },
      {
        "date": "2026-01-30",
        "close": 469.8999938964844
      },
      {
        "date": "2026-02-02",
        "close": 472.010009765625
      },
      {
        "date": "2026-02-03",
        "close": 465.6099853515625
      },
      {
        "date": "2026-02-04",
        "close": 470.5199890136719
      },
      {
        "date": "2026-02-05",
        "close": 458.80999755859375
      },
      {
        "date": "2026-02-06",
        "close": 477.9200134277344
      }
    ],
    "name": "Vertex Pharmaceuticals Incorpor"
  }
}